Respiratory

Latest News


CME Content


The race for a coronavirus disease 2019 (COVID-19) vaccine is one of the most urgent public health challenges, with multiple vaccine candidates entering phase 3 trials and case counts around the world steadily climbing. MJH Life Sciences™ will host a free webinar with the top minds in infectious disease, virology, and vaccinology to discuss the latest trial information on vaccines.

States hardest hit by resurgent cases of coronavirus disease 2019 (COVID-19) have taken steps to either halt or reverse plans to reopen economies; study findings suggest patients with asthma are no more likely than those without asthma to be hospitalized for COVID-19; the Trump administration plans to adopt a decades-old testing strategy called pooled testing that would expand testing efforts in the United States.

Exacerbation of air pollution and heat exposure related to climate change are significantly associated with serious adverse pregnancy outcomes in the United States, results from a systematic review published in JAMA Network Open show. In response to increasing levels of ozone and particle pollution, 17 attorneys general this week called on the Trump administration to strengthen standards regulating particulate matter pollution.

Although the total cost of asthma was more than $80 billion in 2013, the expansion of Medicaid in 2014 aided patients with asthma, according to 2 studies presented at the 2020 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) virtual conference.

Brand Logo

259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831

609-716-7777

© 2025 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo